Curs BNR — 12.11.2026 EUR 5,3459 USD 4,8155 GBP 6,3935

PHARMA

33 articole · RSS

Zentiva Romania Ends 1H/2022 with RON362M Turnover, Up 10%, and RON31.7M Net Profit, Down 8% Vs 1H/2021
Companies

Zentiva Romania Ends 1H/2022 with RON362M Turnover, Up 10%, and RON31.7M Net Profit, Down 8% Vs 1H/2021

Zentiva Romania, a major pharmaceutical manufacturer in Romania, in the first half of this year posted RON362 million turnover, up 10%, and net profit worth RON31.7 million, 8% lower than in the same period of 2021.

Roxana Dumitru Rosu - Mediafax · 01.09.2022 · 10:37 · 1 min
Remedia 2021 Revenues Hit RON472M, Up 7% YOY
Companies

Remedia 2021 Revenues Hit RON472M, Up 7% YOY

Farmaceutica Remedia, a major player on Romania’s pharma market, generated RON472.8 million revenues, up over 7% from the previous year, with the drug distribution unit as the main business...

Georgiana Mihalache · 28.04.2022 · 10:35 · 1 min
Pharma Group Bioeel Hits RON562M Turnover in 2021, Up 18% YOY
Companies

Pharma Group Bioeel Hits RON562M Turnover in 2021, Up 18% YOY

Pharma group Bioeel, owned by businessman Albert Attila, a founding member, and Jean Scheftsik de Szolnok, a French citizen, in 2021 generated turnover worth RON562 million (EUR114.2 million...

Laurentiu Cotu · 22.02.2022 · 09:57 · 1 min
Farmaciile Dona Wants to Strengthen Local Foothold
Companies

Farmaciile Dona Wants to Strengthen Local Foothold

Doctor Eugen Banciu, a stakeholder in Farmaciile Dona, the fourth largest company in Romania’s pharma retail by turnover, wants to strengthen the company locally and says he’s not mulling fo...

Georgiana Mihalache · 23.11.2021 · 09:51 · 1 min
GSK’s Prescription Drugs and Vaccine Division Exits Romania
Health

GSK’s Prescription Drugs and Vaccine Division Exits Romania

Pharmaceutical giant GlaxoSmithKline, which has been operating in Romania for almost 30 years now, has decided to close its pharmaceutical representative office in the country.

Loredana Frățilă-Cristescu · 07.10.2020 · 10:14 · 1 min
A State-Of-The-Art Healthcare System Must Rely on Statistics about Patients and Medicines
Health · ZF Health&Pharma

A State-Of-The-Art Healthcare System Must Rely on Statistics about Patients and Medicines

Implementation of prevention programs so as to lead to an efficient state-of-the-art healthcare system must come from statistical data about the health issues of the patients, which would pr...

Loredana Frățilă-Cristescu · 17.09.2019 · 09:10 · 1 min
Romanian OTC Drug Market Grows 13% in 1Q, to RON880M
Health

Romanian OTC Drug Market Grows 13% in 1Q, to RON880M

Sales of over-the-counter (OTC) medicines topped RON880 million in Romania in the first quarter, up 13% on the year, the local producers association said Tuesday citing Cegedim data.

Oana Gavrila · 15.05.2018 · 15:12 · 1 min
Fiterman Pharma Sees EUR30M Revenue From Drug Production
Health

Fiterman Pharma Sees EUR30M Revenue From Drug Production

Pharmaceutical producer Fiterman Pharma, held by the Fiterman family in Iasi, which also owns the Arcadia medical group, ended last year with 135 million lei (EUR30 million) revenue and RON2...

Loredana Frățilă-Cristescu · 28.06.2017 · 09:11 · 1 min
ZF Health & Pharma '16: Romania’s Healthcare System Problems
Health

ZF Health & Pharma '16: Romania’s Healthcare System Problems

The lack of state-of-the-art equipment in public hospitals, the shortage of physicians in the medical facilities in various parts of the country due to migration abroad and to the private se...

Loredana Frățilă-Cristescu · 14.09.2016 · 09:00 · 3 min